Table 3 Antibiotic sensitivity profile of S. aureus isolates
Antibiotic | Concentration μg /disc | Sensitive No. (%) | Intermediate No. (%) | Resistant No. (%) | Company |
|---|---|---|---|---|---|
Linezolid | 30 μg | 49 (83.1%) | 0 (0%) | 10 (16.9%) | Bioanalyse limited -Turkey |
Tetracycline | 30 μg | 16 (27.1%) | 6 (10.2%) | 37 (62.7%) | Himedia, India |
Chloramphenicol | 30 μg | 42 (71.2%) | 11 (18.6%) | 6 (10.2%) | Bioanalyse limited -Turkey |
Rifampin | 5 μg | 34 (57.6%) | 3 (5.1%) | 22 (37.3%) | Himedia, India |
Piperacillin | 100 μg | 0 (0%) | 0 (0%) | 59 (100%) | Bioanalyse limited -Turkey |
Gentamycin | 10 μg | 29 (49.2%) | 10 (16.9%) | 20 (33.9%) | Himedia, India |
Ampicillin / Sulbactam | 20 μg (10/10 μg) | 5 (8.5%) | 0 (0%) | 54 (91.5%) | Bioanalyse limited -Turkey |
Oxacillin | 1 μg | 5 (8.5%) | 0 (0%) | 54 (91.5%) | Sigma, USA |
Levofloxacin | 5 μg | 33(55.9%) | 5 (8.5%) | 21 (35.6%) | Himedia, India |
Ciprofloxacin | 5 μg | 31 (52.2%) | 7 (11.9%) | 21 (35.6%) | Bioanalyse limited -Turkey |
Amoxicillin/ Clavulanic | 30 μg (20/10 μg) | 5 (8.5%) | 0 (0%) | 54 (91.5%) | Bioanalyse limited -Turkey |
Vancomycin | 30 μg | 51 (86.4%) | 0 (0%) | 8 (13.5%) | Sigma, USA |